Springbok Capital Management Llc decreased its stake in Duke Realty Corp (DRE) by 19.78% based on its latest 2019Q1 regulatory filing with the SEC. Springbok Capital Management Llc sold 18,238 shares as the company’s stock rose 6.01% . The hedge fund held 73,987 shares of the real estate investment trusts company at the end of 2019Q1, valued at $2.26 million, down from 92,225 at the end of the previous reported quarter. Springbok Capital Management Llc who had been investing in Duke Realty Corp for a number of months, seems to be less bullish one the $11.98B market cap company. The stock decreased 1.04% or $0.35 during the last trading session, reaching $33.33. About 4.59M shares traded or 146.24% up from the average. Duke Realty Corporation (NYSE:DRE) has risen 16.66% since August 1, 2018 and is uptrending. It has outperformed by 16.66% the S&P500. Some Historical DRE News: 25/04/2018 – Duke Realty 1Q Net $73.6M; 25/04/2018 – DUKE REALTY SEES FY CORE FFO/SHR $1.26 TO $1.32, EST. $1.27; 25/04/2018 – DUKE REALTY CORP – REVISED ITS GUIDANCE FOR FFO, AS DEFINED BY NAREIT, TO $1.26 TO $1.34 PER DILUTED SHARE FOR 2018; 26/04/2018 – PGGM Investments Adds Duke Realty, Exits Dr Pepper Snapple: 13F; 25/04/2018 – DUKE REALTY CORP DRE.N FY2018 FFO SHR VIEW $1.27 — THOMSON REUTERS l/B/E/S
Quantum Capital Management decreased its stake in Veracyte Inc (VCYT) by 44.76% based on its latest 2019Q1 regulatory filing with the SEC. Quantum Capital Management sold 111,905 shares as the company’s stock rose 12.71% . The institutional investor held 138,115 shares of the health care company at the end of 2019Q1, valued at $3.46M, down from 250,020 at the end of the previous reported quarter. Quantum Capital Management who had been investing in Veracyte Inc for a number of months, seems to be less bullish one the $1.18 billion market cap company. The stock decreased 4.19% or $1.24 during the last trading session, reaching $28.37. About 1.21M shares traded or 52.30% up from the average. Veracyte, Inc. (NASDAQ:VCYT) has risen 160.99% since August 1, 2018 and is uptrending. It has outperformed by 160.99% the S&P500. Some Historical VCYT News: 11/04/2018 – Veracyte Announces Precision Medicine Collaboration With Loxo Oncology; 23/05/2018 – VCYT: AFIRMA GSC IDENTIFY ONE THIRD MORE BENIGN THYROID NODULES; 17/05/2018 – Veracyte Launches Early Access Program for Envisia Genomic Classifier to Improve Diagnosis of IPF; 19/03/2018 – Veracyte Unveils Afirma Xpression Atlas Platform at ENDO 2018; 19/05/2018 – Veracyte Announces That Data From Multiple Studies Demonstrate “Real-World” Value of Afirma Genomic Sequencing Classifier in Thyroid Cancer Diagnosis; 11/04/2018 – VERACYTE REPORTS PRECISION MEDICINE PACT WITH LOXO ONCOLOGY; 19/03/2018 – Veracyte Announces New Data Suggesting Afirma GSC’s Ability to Help Significantly More Patients Avoid Unnecessary Thyroid; 19/05/2018 – Veracyte: Afirma GSC Identified Significantly More Benign Thyroid Nodules Among Those Deemed Indeterminate; 22/04/2018 – DJ Veracyte Inc, Inst Holders, 1Q 2018 (VCYT); 11/04/2018 – VERACYTE INC – FINANCIAL AND OTHER TERMS OF AGREEMENT WERE NOT DISCLOSED
Since February 11, 2019, it had 0 buys, and 2 selling transactions for $1.67 million activity. Anderson Bonnie H sold $145,364 worth of stock or 8,000 shares.
More notable recent Veracyte, Inc. (NASDAQ:VCYT) news were published by: Benzinga.com which released: “60 Biggest Movers From Yesterday – Benzinga” on July 24, 2019, also Benzinga.com with their article: “Benzinga’s Top Upgrades, Downgrades For July 2, 2019 – Benzinga” published on July 02, 2019, Benzinga.com published: “The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation – Benzinga” on July 23, 2019. More interesting news about Veracyte, Inc. (NASDAQ:VCYT) were released by: Benzinga.com and their article: “Benzinga’s Top Upgrades, Downgrades For July 31, 2019 – Benzinga” published on July 31, 2019 as well as Finance.Yahoo.com‘s news article titled: “Veracyte (VCYT) Q2 2019 Earnings Call Transcript – Yahoo Finance” with publication date: July 31, 2019.
Quantum Capital Management, which manages about $700.30 million and $185.66 million US Long portfolio, upped its stake in Aquantia Corp by 69,121 shares to 264,630 shares, valued at $2.40M in 2019Q1, according to the filing. It also increased its holding in International Business Machs (NYSE:IBM) by 2,944 shares in the quarter, for a total of 6,349 shares, and has risen its stake in Sientra Inc (NASDAQ:SIEN).
Investors sentiment decreased to 1.23 in 2019 Q1. Its down 0.14, from 1.37 in 2018Q4. It dropped, as 10 investors sold VCYT shares while 46 reduced holdings. 31 funds opened positions while 38 raised stakes. 30.00 million shares or 8.65% more from 27.61 million shares in 2018Q4 were reported. Legal And General Group Inc Plc invested in 4,624 shares or 0% of the stock. Acuta Cap Ltd Liability Corp holds 381,500 shares. Sei Comm reported 0.01% of its portfolio in Veracyte, Inc. (NASDAQ:VCYT). Citadel Advsr Ltd Liability holds 0% of its portfolio in Veracyte, Inc. (NASDAQ:VCYT) for 209,769 shares. Caxton Associate Ltd Partnership holds 21,432 shares or 0.08% of its portfolio. Franklin Res Inc accumulated 25,100 shares. D E Shaw & Comm stated it has 290,289 shares. Acadian Asset Lc reported 0.04% stake. Next Century Growth Investors Ltd has 2.43% invested in Veracyte, Inc. (NASDAQ:VCYT) for 726,554 shares. Eam Investors Lc holds 196,593 shares. Affinity Investment Advisors Limited Liability stated it has 0.19% of its portfolio in Veracyte, Inc. (NASDAQ:VCYT). Meeder Asset Mgmt Inc has invested 0.01% in Veracyte, Inc. (NASDAQ:VCYT). Los Angeles Mngmt And Equity Inc reported 11,145 shares. Neuberger Berman Gp Limited Liability Company owns 20,000 shares. Dsam Prns (London) Limited invested 0.03% in Veracyte, Inc. (NASDAQ:VCYT).
Since February 1, 2019, it had 0 insider purchases, and 1 insider sale for $1.37 million activity. Anthony Nicholas C. sold $288,869 worth of stock or 9,937 shares.
Investors sentiment decreased to 0.96 in Q1 2019. Its down 0.13, from 1.09 in 2018Q4. It dived, as 21 investors sold DRE shares while 136 reduced holdings. 37 funds opened positions while 113 raised stakes. 325.57 million shares or 0.01% more from 325.55 million shares in 2018Q4 were reported. Kentucky Retirement System Ins Trust Fund holds 0.05% or 7,142 shares in its portfolio. Robeco Institutional Asset Mngmt Bv has invested 0.04% in Duke Realty Corporation (NYSE:DRE). 4.65M are owned by Nuveen Asset Ltd Limited Liability Company. 964,634 are held by Asset Mgmt One Limited. Bp Public Ltd Liability Corp invested in 0.09% or 78,000 shares. State Of Wisconsin Inv Board holds 0.06% of its portfolio in Duke Realty Corporation (NYSE:DRE) for 672,563 shares. Moreover, Df Dent & has 0.01% invested in Duke Realty Corporation (NYSE:DRE). Sumitomo Mitsui Asset Mgmt Limited stated it has 40,711 shares. Pensionfund Dsm Netherlands stated it has 38,024 shares. 29,894 were accumulated by Eaton Vance. Oregon Employees Retirement Fund holds 0.02% of its portfolio in Duke Realty Corporation (NYSE:DRE) for 36,943 shares. Bollard Grp Inc Limited Liability Com accumulated 117,871 shares or 0.14% of the stock. Bartlett Ltd Liability Corporation accumulated 522 shares. Zeke Cap Advsr has 14,148 shares. Wespac Advsr Llc, a California-based fund reported 28,087 shares.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.